ArticleBlood cancer journal2017

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

C Pawlyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.